Scribe Therapeutics Inc. · NASDAQ:SCTX

Marc L. Andreessen reported a 16.30% stake in Scribe Therapeutics Inc. (Schedule 13G)

Event Sep 30, 2026 · Filed Nov 16, 2026

Marc L. Andreessen reported a 16.30% stake in Scribe Therapeutics Inc., 3,082,725 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G).

Stake
16.30%
Shares
3,082,725
Intent
Passive
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
AH Bio Fund II, L.P.12.60%2,385,075
AH Equity Partners Bio II, L.L.C.12.60%2,385,075
AH Bio Fund III, L.P.3.70%697,650
AH Equity Partners Bio III, L.L.C.3.70%697,650
Marc L. Andreessen16.30%3,082,725
Benjamin A. Horowitz16.30%3,082,725

Source

Download original · View original at SEC

Related